BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17517949)

  • 1. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
    Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
    Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
    Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
    J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
    Arens J; Barnes K; Crowley N; Maartens G
    S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis].
    Fernández-Ayala M; Fariñas MC; Nan D; González-Macías J
    An Med Interna; 2000 Nov; 17(11):616-7. PubMed ID: 11322040
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases.
    Hein R; Brunkhorst R; Thon WF; Schedel I; Schmidt RE
    Clin Nephrol; 1993 May; 39(5):254-6. PubMed ID: 8513601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
    Iribarren JA; Arrizabalaga J; Garde C; Rodriguez-Arrondo F; Blanco A
    Arch Intern Med; 1992 Oct; 152(10):2139-40. PubMed ID: 1417389
    [No Abstract]   [Full Text] [Related]  

  • 12. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxoplasma encephalitis in a previously healthy man].
    Kupila L; Sonninen V; Peltonen R; Uksila J; Hukkanen V; Kotilainen P
    Duodecim; 1999; 115(3):284-8. PubMed ID: 11830874
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
    Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
    Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
    Arjol AM; Sánchez C; Dalmau D
    Enferm Infecc Microbiol Clin; 1998 May; 16(5):250-1. PubMed ID: 9666594
    [No Abstract]   [Full Text] [Related]  

  • 16. A solitary brain lesion in a patient with AIDS.
    Ball SC
    AIDS Read; 2003 Jan; 13(1):11-4. PubMed ID: 12569890
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
    Torre D; Casari S; Speranza F; Donisi A; Gregis G; Poggio A; Ranieri S; Orani A; Angarano G; Chiodo F; Fiori G; Carosi G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1346-9. PubMed ID: 9624473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
    Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.